NCT07435493

Brief Summary

Emphasize that the usage of multimodal analgesia in managing perioperative pain in children with mild to moderate Obstructive Sleep Apnea undergoing adenotonsillectomy may achieve the same efficacy of fentanyl with less respiratory complications and less opioid-related side effects.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Nov 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2026

Completed
29 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
9 months until next milestone

Study Start

First participant enrolled

November 30, 2026

Expected
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

February 27, 2026

Status Verified

January 1, 2026

Enrollment Period

Same day

First QC Date

January 29, 2026

Last Update Submit

February 23, 2026

Conditions

Keywords

opioidFentanylobstructive sleep apneaadenotonsillectomy

Outcome Measures

Primary Outcomes (1)

  • FLACC Scale (face, legs, activity, cry, consolability)

    It grades pain from 0 to 10 by observing five categories-Face, Legs, Activity, Cry, and Consolability-with each item scored 0-2.

    at 0 hours, 2hours, and 6 hours postoperatively

Secondary Outcomes (1)

  • Time to oral intake

    6 hours postoperatively

Study Arms (2)

Fentanyl-Based Analgesia group

EXPERIMENTAL

Fentanyl-Based Analgesia will receive intraoperative fentanyl (1 μg/kg IV) with standard anesthetic care with postoperative rescue analgesia with acetaminophen (15 mg/kg) as needed.

Drug: Group A: Fentanyl-Based Analgesia

Opioid-Free Multimodal Analgesia group

EXPERIMENTAL

Opioid-Free Multimodal Analgesia will receive preoperative acetaminophen (15 mg/kg) and ibuprofen (10 mg/kg), intraoperative ketamine (0.5 mg/kg IV) and dexamethasone (0.1 mg/kg IV) with postoperative rescue analgesia with acetaminophen as needed.

Drug: Group B: Opioid-Free Multimodal Analgesia

Interventions

Fentanyl-Based Analgesia will receive intraoperative fentanyl (1 μg/kg IV) with standard anesthetic care with postoperative rescue analgesia with acetaminophen (15 mg/kg) as needed

Fentanyl-Based Analgesia group

Opioid-Free Multimodal Analgesia will receive preoperative acetaminophen (15 mg/kg) and ibuprofen (10 mg/kg), intraoperative ketamine (0.5 mg/kg IV) and dexamethasone (0.1 mg/kg IV) with postoperative rescue analgesia with acetaminophen as needed.

Opioid-Free Multimodal Analgesia group

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 5-10 years.
  • Diagnosed with mild to moderate Obstructive Sleep Apnea (apnea-hypoxia index 1-10).
  • Scheduled for elective adenotonsillectomy.
  • American Society of Anesthesiologists physical status I-II.

You may not qualify if:

  • Severe Obstructive Sleep Apnea (apnea-hypoxia index \>10).
  • Known allergies to study medications.
  • Patient with predicted difficult air way (Mallampatti 3\&4).
  • History of opioid use or chronic pain syndromes.
  • Neurological or metabolic disorders affecting pain perception.
  • Parental refusal to consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain shams university

Cairo, Egypt

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Central Study Contacts

Anhar Falila, Assistant Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident in anesthesiology, faculty of medicine, Ain shams university

Study Record Dates

First Submitted

January 29, 2026

First Posted

February 27, 2026

Study Start (Estimated)

November 30, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

February 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

All data ill be available when it needed

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations